Vosevi (Generic Voxilaprevir-Velpatasvir-Sofosbuvir): Complete Medication Guide
Key Takeaways
Vosevi is a combination antiviral medication that treats hepatitis C in most patient types, including those with cirrhosis.
It works by blocking three different viral proteins that hepatitis C needs to survive and multiply.
Most people achieve a cure (sustained viral response) with 12 weeks of treatment.
Side effects are generally mild, with fatigue and headache being most common.
Serious drug interactions are possible, so always review your full medication list with your doctor.
Vosevi Overview
Vosevi is a combination antiviral medication used to treat chronic hepatitis C virus (HCV) infection. This triple-drug combination contains voxilaprevir, velpatasvir, and sofosbuvir—three medicines that work together to stop the virus from replicating in your body. The generic version of Vosevi is chemically identical to the brand-name medication and costs significantly less than brand-name drugs.
Hepatitis C is a serious liver infection that can lead to cirrhosis, liver failure, and liver cancer if left untreated. For decades, hepatitis C treatment was difficult and had many side effects. Vosevi represents a major breakthrough—it offers a cure for most patients in just 12 weeks with few uncomfortable effects.
The medication works by blocking three different proteins the hepatitis C virus needs to survive. Voxilaprevir stops a protease enzyme, velpatasvir blocks an NS5A protein, and sofosbuvir inhibits an RNA polymerase. By attacking the virus in multiple ways at once, this combination approach prevents the virus from developing resistance and achieves cure rates above 95% in most patient groups. Your doctor may prescribe Vosevi if you have hepatitis C, whether or not you've been treated before, and even if you have cirrhosis or liver scarring.
Side Effects
Vosevi is generally well tolerated. Most people experience mild symptoms, and many have no side effects at all. Serious problems are uncommon but may happen in people taking certain other medications.
Common Side Effects
Fatigue — Feeling tired or low on energy is the most frequently reported side effect. It usually improves as your body adjusts to the medication.
Headache — Mild to moderate headaches may occur, particularly during the first few weeks of treatment.
Nausea — Some people experience mild stomach upset or queasiness. Taking the medication with food may help.
Diarrhea — Loose stools are possible but usually mild and manageable with dietary adjustments.
Insomnia — Sleep disturbances or difficulty falling asleep may occur in some patients.
Muscle or joint pain — Mild aches may develop, though they typically resolve as treatment continues.
Serious Side Effects
Severe liver problems — In rare cases, liver function may worsen significantly. Patients with existing cirrhosis need close monitoring.
Bradycardia — A dangerously slow heart rate may occur, especially when combined with certain heart medications like amiodarone.
Severe allergic reactions — Rash, difficulty breathing, or swelling of the face or throat requires immediate medical attention.
Hepatic decompensation — In people with advanced cirrhosis, the liver may fail. Your doctor will monitor this closely.
Depression or mood changes — Unusual emotional or behavioral changes have been reported and should be discussed with your healthcare provider.
When to Seek Medical Attention
Contact your doctor immediately if you experience chest pain, severe shortness of breath, fainting, yellowing of the skin or eyes, dark urine, severe abdominal pain, or thoughts of self-harm. These symptoms may indicate a serious reaction that needs prompt evaluation.
For mild side effects like fatigue or headache, give your body time to adjust over the first 1–2 weeks. If symptoms persist or worsen after that, call your doctor. Never stop taking Vosevi without your doctor's approval, even if side effects bother you—your healthcare provider can help manage them or adjust your treatment plan.
Dosage
Dose Level or Form |
Dose |
Key Detail |
Standard tablet (all patients) |
1 tablet once daily |
Contains voxilaprevir 100 mg + velpatasvir 100 mg + sofosbuvir 400 mg |
Treatment duration (treatment-naive) |
12 weeks |
For patients with no prior HCV treatment |
Treatment duration (treatment-experienced) |
12 weeks |
For patients previously treated with certain HCV medications |
Treatment duration (cirrhotic patients) |
12 weeks |
May be extended to 24 weeks in some cases—discuss with your doctor |
Food requirement |
Take with or without food |
May take with food to reduce nausea if needed |
Important: Take Vosevi exactly as prescribed, every single day for the full treatment period. If you miss a dose, take it as soon as you remember unless it's almost time for your next dose—then skip the missed dose and resume your regular schedule. Do not double up on doses. Missing doses or stopping early can allow the virus to develop resistance to the medication. If you have questions about a missed dose, contact your pharmacy or doctor immediately.
Drug Interactions
Vosevi can interact with many medications and supplements. Some interactions may reduce how well Vosevi works, while others may increase the risk of serious side effects. Always provide your doctor and pharmacist with a complete list of everything you take—including over-the-counter drugs, vitamins, and herbal supplements.
Amiodarone and other heart rhythm medications
Amiodarone combined with sofosbuvir (one of Vosevi's ingredients) may cause a dangerous drop in heart rate, especially in older adults or those with heart problems. Your doctor may need to monitor your heart closely or choose a different heart medication.
St. John's Wort (herbal supplement)
This common herbal supplement significantly reduces blood levels of velpatasvir and voxilaprevir, making Vosevi less effective at fighting hepatitis C. Avoid St. John's Wort entirely during treatment.
Rifampin and rifabutin (tuberculosis medications)
These drugs greatly decrease Vosevi levels in your bloodstream, making it unlikely to cure hepatitis C. If you need TB treatment, discuss alternative options with your doctor.
Proton pump inhibitors and H2 blockers (acid reflux medicines)
Strong acid-reducing medications may decrease velpatasvir absorption. Your doctor may recommend taking Vosevi on a specific schedule separate from these medications or switching to a different acid reflux treatment.
Certain antiretroviral medications (HIV drugs)
Some HIV medications, particularly those containing protease inhibitors or integrase inhibitors, may interact with Vosevi components. Patients with both HIV and hepatitis C need careful monitoring and possible dose adjustments.
P-gp inducers (various medications and supplements)
Drugs that induce P-glycoprotein, an important drug transporter, may reduce Vosevi effectiveness. Always discuss all supplements and medications with your healthcare provider before starting treatment.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
High cure rates — Over 95% of patients achieve sustained viral response (SVR), meaning the virus is eliminated and doesn't return.
Short treatment duration — Most patients are cured in just 12 weeks, compared to longer treatments in the past.
Mild side effect profile — Most people tolerate Vosevi well with few or no uncomfortable symptoms.
Works for most patient types — Effective in treatment-naive patients, those previously treated, and those with cirrhosis.
Once-daily dosing — Simple one-tablet-once-daily regimen improves compliance and makes treatment easier to fit into daily life.
Cons
Significant drug interactions — Many medications reduce effectiveness or increase risks, limiting treatment options for some patients.
Cost — While the generic version costs less than brand Vosevi, the medication is still expensive; however, patient assistance programs may help.
Requires careful liver monitoring — Patients need regular blood tests before, during, and after treatment to ensure safety and effectiveness.
Not suitable for certain populations — Patients with specific kidney, heart, or drug-interaction issues may not be candidates.
Hepatitis B reactivation risk — Those with hepatitis B history require additional monitoring and possibly preventive antiviral therapy.
Frequently Asked Questions
Get answers to common questions about Vosevi and hepatitis C treatment.
Vosevi begins fighting the virus immediately, but your body needs time to clear it. Most patients achieve sustained viral response (SVR)—the definition of cure—within 4–12 weeks after completing treatment. Your doctor will perform a blood test 12 weeks after your final dose to confirm the cure. Once SVR is achieved, the hepatitis C virus is gone and will not return in nearly all cases.
No, you must complete the full 12-week treatment course even if you feel fine. The virus may still be present if you stop early, and it could develop resistance to the medication. This resistance might make future treatments less effective. Always follow your doctor's instructions and take every dose as prescribed.
Vosevi actually protects your liver by eliminating the hepatitis C virus, which is what damages it. In fact, curing hepatitis C stops further liver damage and allows existing scarring to partially reverse over time. For patients with cirrhosis, treatment with Vosevi reduces the risk of liver failure and cancer significantly. Regular monitoring ensures your doctor catches any issues early.
Yes, generic voxilaprevir-velpatasvir-sofosbuvir is chemically identical to brand-name Vosevi. Generic and brand-name drugs are equally effective because they contain the same active ingredients in the same doses. The main difference is cost—the generic version is significantly less expensive. Both are equally safe and effective at curing hepatitis C.
After completing treatment, your doctor will test your blood 12 weeks later to confirm SVR. If the virus is gone at that point, you're cured. Going forward, you'll need regular liver monitoring (typically annual ultrasound or blood work) to watch for signs of liver damage from past infection. You cannot get hepatitis C again from the same virus strain, though reinfection from a new exposure is theoretically possible. Most cured patients live normal, healthy lives without restrictions.
The Bottom Line
Vosevi (generic voxilaprevir-velpatasvir-sofosbuvir) represents a major breakthrough in hepatitis C treatment, offering cure rates above 95% in just 12 weeks with minimal side effects for most patients. This triple-combination antiviral is effective whether you're being treated for the first time or have received prior therapy, and it works in patients with cirrhosis. While drug interactions and liver monitoring require careful attention, the opportunity to eliminate a serious liver infection and prevent future damage makes Vosevi a game-changing option. If you have hepatitis C, discussing Vosevi with your doctor could be the first step toward becoming hepatitis-C free. At Doctronic, we're here to help—as the first AI legally authorized to practice medicine, we can answer your health questions 24/7. Get a free AI consultation or schedule a video visit with a real doctor today to explore your treatment options.
